NM_024411.5:c.600T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024411.5(PDYN):​c.600T>C​(p.His200His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,613,502 control chromosomes in the GnomAD database, including 13,351 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2318 hom., cov: 31)
Exomes 𝑓: 0.12 ( 11033 hom. )

Consequence

PDYN
NM_024411.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.93

Publications

22 publications found
Variant links:
Genes affected
PDYN (HGNC:8820): (prodynorphin) The protein encoded by this gene is a preproprotein that is proteolytically processed to form the secreted opioid peptides beta-neoendorphin, dynorphin, leu-enkephalin, rimorphin, and leumorphin. These peptides are ligands for the kappa-type of opioid receptor. Dynorphin is involved in modulating responses to several psychoactive substances, including cocaine. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
PDYN-AS1 (HGNC:53462): (PDYN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 20-1980488-A-G is Benign according to our data. Variant chr20-1980488-A-G is described in ClinVar as Benign. ClinVar VariationId is 337834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.93 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.275 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDYNNM_024411.5 linkc.600T>C p.His200His synonymous_variant Exon 4 of 4 ENST00000217305.3 NP_077722.1 P01213

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDYNENST00000217305.3 linkc.600T>C p.His200His synonymous_variant Exon 4 of 4 1 NM_024411.5 ENSP00000217305.2 P01213

Frequencies

GnomAD3 genomes
AF:
0.155
AC:
23448
AN:
151562
Hom.:
2312
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.279
Gnomad AMI
AF:
0.0901
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.00155
Gnomad SAS
AF:
0.0627
Gnomad FIN
AF:
0.0799
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.175
GnomAD2 exomes
AF:
0.106
AC:
26563
AN:
251350
AF XY:
0.103
show subpopulations
Gnomad AFR exome
AF:
0.285
Gnomad AMR exome
AF:
0.0784
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0795
Gnomad NFE exome
AF:
0.119
Gnomad OTH exome
AF:
0.122
GnomAD4 exome
AF:
0.115
AC:
168373
AN:
1461820
Hom.:
11033
Cov.:
33
AF XY:
0.114
AC XY:
82707
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.291
AC:
9749
AN:
33476
American (AMR)
AF:
0.0832
AC:
3719
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
3039
AN:
26136
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39700
South Asian (SAS)
AF:
0.0693
AC:
5978
AN:
86252
European-Finnish (FIN)
AF:
0.0814
AC:
4351
AN:
53420
Middle Eastern (MID)
AF:
0.188
AC:
1085
AN:
5768
European-Non Finnish (NFE)
AF:
0.120
AC:
133207
AN:
1111950
Other (OTH)
AF:
0.120
AC:
7237
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
9320
18640
27961
37281
46601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4850
9700
14550
19400
24250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.155
AC:
23480
AN:
151682
Hom.:
2318
Cov.:
31
AF XY:
0.151
AC XY:
11159
AN XY:
74098
show subpopulations
African (AFR)
AF:
0.279
AC:
11523
AN:
41308
American (AMR)
AF:
0.122
AC:
1864
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
417
AN:
3468
East Asian (EAS)
AF:
0.00156
AC:
8
AN:
5136
South Asian (SAS)
AF:
0.0638
AC:
306
AN:
4796
European-Finnish (FIN)
AF:
0.0799
AC:
842
AN:
10540
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.118
AC:
8003
AN:
67874
Other (OTH)
AF:
0.174
AC:
367
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
940
1881
2821
3762
4702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.131
Hom.:
2810
Bravo
AF:
0.165
Asia WGS
AF:
0.0500
AC:
175
AN:
3478
EpiCase
AF:
0.124
EpiControl
AF:
0.129

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spinocerebellar ataxia type 23 Benign:4
Oct 10, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Sep 20, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.012
DANN
Benign
0.36
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6045819; hg19: chr20-1961134; COSMIC: COSV54103447; API